Tg Therapeutics Stock Price on November 20, 2024
| TGTX Stock | USD 33.50 1.34 4.17% |
Below is the normalized historical share price chart for TG Therapeutics extending back to December 14, 1995. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of TG Therapeutics stands at 33.50, as last reported on the 26th of December, with the highest price reaching 33.50 and the lowest price hitting 31.86 during the day.
If you're considering investing in TGTX Stock, it is important to understand the factors that can impact its price. TG Therapeutics appears to be not too volatile, given 3 months investment horizon. TG Therapeutics retains Efficiency (Sharpe Ratio) of 0.15, which indicates the firm had a 0.15% return per unit of price deviation over the last 3 months. By examining TG Therapeutics' technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please review TG Therapeutics' Downside Deviation of 3.86, risk adjusted performance of 0.1185, and Mean Deviation of 3.0 to confirm if our risk estimates are consistent with your expectations.
At this time, TG Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 155.9 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 74.7 K in 2024. . At this time, TG Therapeutics' Price Earnings Ratio is fairly stable compared to the past year. Price Book Value Ratio is likely to rise to 15.86 in 2024, whereas Price To Sales Ratio is likely to drop 9.86 in 2024. TGTX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 14th of December 1995 | 200 Day MA 21.5636 | 50 Day MA 29.7524 | Beta 2.193 |
TGTX |
Sharpe Ratio = 0.1457
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TGTX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.28 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.62 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average TG Therapeutics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TG Therapeutics by adding it to a well-diversified portfolio.
Price Book 26.0526 | Enterprise Value Ebitda 844.8925 | Price Sales 18.9063 | Shares Float 133.6 M | Wall Street Target Price 40.75 |
Related Headline
Akero Therapeutics Headline on 20th of November 2024
LMR Partners LLP Raises Stock Position in Akero Therapeutics... by thelincolnianonline.com
LMR Partners LLP increased its position in shares of Akero Therapeutics, Inc. by 17.0 percent in the 3rd quarter, HoldingsChannel reports. The fund owned 20,597 shares of the companys stock after acquiring an additional 2,997 shares during the period. LMR Partners LLPs holdings in Akero Therapeutics were worth 591,000 as of its
TG Therapeutics Valuation on November 20, 2024
It is possible to determine the worth of TG Therapeutics on a given historical date. On November 20, 2024 TGTX was worth 30.45 at the beginning of the trading date compared to the closed value of 31.15. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of TG Therapeutics stock. Still, in general, we apply an absolute valuation method to find TG Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of TG Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against TG Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 29.52 | 30.37 | 29.42 | 30.32 | 2,153,176 | |
11/20/2024 | 30.45 | 32.00 | 29.91 | 31.15 | 2,226,409 |
| 31.61 | 36.40 | 31.36 | 34.55 | 5,838,364 |
| Backtest TG Therapeutics | | | TG Therapeutics History | | | TG Therapeutics Valuation | Previous | Next |
TG Therapeutics Trading Date Momentum on November 20, 2024
| On November 21 2024 TG Therapeutics was traded for 34.55 at the closing time. The top price for the day was 36.40 and the lowest listed price was 31.36 . The trading volume for the day was 5.8 M. The trading history from November 21, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 10.91% . The trading price change against the current closing price is 11.27% . |
TG Therapeutics Fundamentals Correlations and Trends
By evaluating TG Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among TG Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. TGTX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About TG Therapeutics Stock history
TG Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for TGTX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in TG Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing TG Therapeutics stock prices may prove useful in developing a viable investing in TG Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 148.5 M | 155.9 M | |
| Net Loss | -164.4 M | -172.6 M |
TG Therapeutics Quarterly Net Working Capital |
|
TG Therapeutics Stock Technical Analysis
TG Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
TG Therapeutics Period Price Range
Low | December 26, 2024
| High |
0.00 | 0.00 |
TG Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
TG Therapeutics December 26, 2024 Market Strength
Market strength indicators help investors to evaluate how TG Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TG Therapeutics shares will generate the highest return on investment. By undertsting and applying TG Therapeutics stock market strength indicators, traders can identify TG Therapeutics entry and exit signals to maximize returns
TG Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for TG Therapeutics' price direction in advance. Along with the technical and fundamental analysis of TGTX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of TGTX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1185 | |||
| Jensen Alpha | 0.4906 | |||
| Total Risk Alpha | 0.3866 | |||
| Sortino Ratio | 0.1383 | |||
| Treynor Ratio | 0.2528 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for TGTX Stock Analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.